Cozart, Nemesis Scientific Ltd. deal

CZT acquired Nemesis for £1.1 million ($2.2 million). Nemesis shareholders are eligible for £400,000 ($780,000) in revenue milestones over the next two years. Nemesis provides workplace drug and alcoh...